Affiliation:
1. University of Zagreb, School of Medicine
2. University Hospital Dubrava
3. Agency for Medicinal Products and Medical Devices
4. Division of pharmacogenomics and therapy individualization, University Hospital Center Zagreb, Croatia
5. Analytical toxicology and pharmacology division, University Hospital Center Zagreb, Zagreb
Abstract
Abstract
Purpose. To estimate whether epilepsy patients with variant UGT2B7 -161C>T(rs7668258) or UGT1A4*3 c.142T>G(rs2011425) alleles differ from their wild-type (wt) peers in exposure to lamotrigine.
Methods. Consecutive adults on lamotrigine monotherapy or lamotrigine+valproate co-treatment undergoing routine therapeutic drug monitoring, otherwise generally healthy and free of interacting drugs, were genotyped for UGT2B7 -161C>T and UGT1A4*3 c.142T>G. Heterozygous, variant homozygous, or combined heterozygous/variant homozygous subjects were compared to their wt controls for dose-adjusted lamotrigine troughs with adjustment for age, sex, body weight, rs7668258/rs2011425, polymorphisms of efflux transporter proteins ABCG2 c.421C>A (rs2231142) and ABCB1 1236C>T (rs1128503), and level of exposure to valproate using covariate entropy balancing.
Results. Of the 471 included patients, 328 (69.6%) were on monotherapy and 143 were co-treated with valproate. Dose-adjusted lamotrigine troughs in UGT2B7 -161C>T heterozygous (CT, n=237) or variant homozygous (TT, n=115) subjects were closely similar to those in their wt controls (CC, n=119): geometric means ratios (GMRs) (frequentist and Bayes) 1.00 (95%CI 0.86-1.16) and 1.00 (95%CrI 0.83-1.22) for CT vs. CC; and 0.97 (0.81-1.17) and 0.97 (0.80-1.20) for TT vs. CC subjects. Lamotrigine troughs were also closely similar in UGT1A4*3 c.142T>G variant carriers [n=106: 102 TG + 4 GG subjects) and wt controls (TT, n=365): GMR= 0.95 (0.81-1.12) frequentist, 0.96 (0.80-1.16) Bayes. GMRs for variant carriers vs. wt controls were around unity also at different levels of exposure to valproate.
Conclusion. Dose-adjusted lamotrigine troughs in epilepsy patients with variant UGT2B7 -161C>T or UGT1A4*3 c.142T>G alleles are equivalent to those in their respective wt peers.
Publisher
Research Square Platform LLC